Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1477 of 6351
-
Smart patch listens for breathing danger in opioid patients
Diagnosis By invitation onlyThis study is being conducted to evaluate the ability of the Respiratory Monitoring System (RMS) to detect and predict opioid induced respiratory depression (OIRD) in post-operative surgical patients managed with opioid medications. The ability of the RMS to detect OIRD will be c…
Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New hope for rare cancers: drug combo shows promise in early trial
Disease control Recruiting nowBackground: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It can be hard to study treatments for these diseases. One combination of drugs-enfortumab vedotin (EV) and pembrolizumab-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Psoriasis drug combo aims to tackle skin and cholesterol in one shot
Disease control Not yet recruitingThe aim is to evaluate the safety and efficacy of vunakizumab combined with recaticimab versus vunakizumab combined with placebo in the treatment of plaque psoriasis with dyslipidemia.
Phase 4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental 'Off-the-Shelf' NK cells aim to fight childhood leukemia
Disease control Not yet recruitingThis is a single-arm, open-label, dose-escalation and expansion, prospective clinical trial conducted in patients with relapsed or refractory pediatric B-cell acute lymphoblastic leukemia to evaluate the safety and efficacy of JY509 universal NK cell injection.
Early phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Radioactive drug plus immunotherapy shows promise for tough lung cancer
Disease control Recruiting nowThis is a phase I study to evaluate the safety and preliminary efficacy of \[225Ac\]Ac-DOTATATE injection combined with tislelizumab in the maintenance treatment period for patients of extensive-stage small cell lung cancer (ES-SCLC) with somatostatin receptors (SSTR)+ as first-l…
Phase 1 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study tests simple ways to prevent dangerous sodium drop after brain surgery
Prevention Recruiting nowThe investigators are conducting this study to investigate new preventive measures for patients with low sodium levels (hyponatremia), which can occur after surgery on the pituitary gland. This hyponatremia is often caused by the syndrome of inappropriate antidiuresis (SIAD). SIA…
Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New antibody trio takes on Hard-to-Treat lymphoma
Disease control Recruiting nowThe purpose of this study is to determine the putative recommended Phase 2 doses (RP2Ds) and optimal dose schedule(s) for JNJ-95566692 as a single agent (Arm A) and in combination with JNJ-87801493 (Arm B) (Part 1: Dose Escalation) and to further characterize the safety and clini…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New pill could replace steroids for painful muscle condition
Disease control Not yet recruitingThe study intends to explore the efficacy and safety of Ivarmacitinib in therapy for polymyalgia rheumatica through a multicenter, randomized, double-blind, placebo-controlled study, and to explore the effectiveness of Ivarmacitinib as an oral glucocorticoid-sparing alternative i…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for advanced GI cancers: first human trial launches
Disease control Recruiting nowThis study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Phase 1/2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New triple therapy aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis open-label, single-arm study is designed to evaluate the safety and preliminary efficacy of NK010 cell injection combined with a PD-1 antibody and platinum-based chemotherapy as neoadjuvant therapy in patients with resectable non-small cell lung cancer (NSCLC). The study aim…
Phase 1 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Robot-Assisted microsurgery: a new frontier for tissue repair and lymphedema
Disease control Recruiting nowThe objective of this clinical study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphatic surgery. The primary endpoints are: Effectiveness: Clinical Success, defined as intraoperative anasto…
Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New vaccine aims to shield infants from pneumonia
Prevention Recruiting nowThis is a phase 3 randomized, modified double-blind study whose purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help the body to develop germ-fighting agents called "antibodies" (immunogenicity) in a similar way (ie, same immune response…
Phase 3 • Sponsor: Sanofi • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
New study tests gentler way to give lung medicine to preterm infants
Disease control Recruiting nowRespiratory distress syndrome (RDS) is a common cause of respiratory failure in preterm infants and is frequently treated with surfactant therapy. With the increasing use of noninvasive ventilation, less invasive methods of surfactant administration have been developed. In the te…
Phase 4 • Sponsor: Uludag University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
AI art therapy aims to ease chemo anxiety in kids
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the effects of an AI-assisted interactive art therapy co-creation intervention on symptom burden, state anxiety, and emotional regulation in pediatric patients receiving chemotherapy. The study will be conducted as a parallel-grou…
Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a common diabetes drug shield heart transplant patients from kidney damage?
Disease control Recruiting nowHeart transplant (HTx) is an established therapy for advanced heart disease that restores quality of life and improves survival. However, due to preexisting comorbidities combined with the immunosuppressive therapies required after transplantation, HTx recipients remain at high r…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Ultrasound-Guided procedure could reduce bleeding risk in cirrhosis patients
Disease control Not yet recruitingBleeding from esophagogastric varices in patients with liver cirrhosis is often life-threatening. Thrombocytopenia caused by hypersplenism secondary to portal hypertension is an independent risk factor for such gastrointestinal bleeding. Studies have confirmed that partial spleni…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo aims to prevent transplant complications
Disease control Recruiting nowThe researchers are doing this study to compare 2 different GVHD prevention (prophylaxis) approaches. The researchers will see which approach is good or more effective at preventing chronic GVHD until 1 year after allogeneic hematopoietic stem cell transplantation (allo-HCT).
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New depression pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Spinal cord stimulation study aims to fine-tune movement without surgery
Knowledge-focused Recruiting nowSpinal cord injury leads to long-lasting impairment, and currently, there is no cure for paralysis. Although transcutaneous spinal cord stimulation has shown promising results in recovering lost movements, its poor selectivity in muscle recruitment compared to invasive approaches…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can East-Meet-West medicine slow spine damage in ankylosing spondylitis?
Disease control Recruiting nowThis study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to eva…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC